These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10683548)

  • 1. Cost-benefit analysis of the Polish hepatitis B prevention programme.
    Wiewióra-Pilecka D
    Vaccine; 2000 Feb; 18 Suppl 1():S52-4. PubMed ID: 10683548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of hepatitis A and B vaccination programme in Germany.
    Szucs T
    Vaccine; 2000 Feb; 18 Suppl 1():S86-9. PubMed ID: 10683559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic evaluation of universal vaccination against hepatitis B virus.
    Fenn P; Gray A; McGuire A
    J Infect; 1996 May; 32(3):197-204. PubMed ID: 8793708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.
    Siddiqui MR; Gay N; Edmunds WJ; Ramsay M
    Vaccine; 2011 Jan; 29(3):466-75. PubMed ID: 21073988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-benefit analysis of the introduction of mass vaccination against hepatitis B in Italy.
    Demicheli V; Jefferson TO
    J Public Health Med; 1992 Dec; 14(4):367-75. PubMed ID: 1489561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
    Sun PP; Zhang SX; Xia Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
    [No Abstract]   [Full Text] [Related]  

  • 8. The expanded programme on immunization calendar in Poland.
    Galimska J
    Vaccine; 2000 Feb; 18 Suppl 1():S41-3. PubMed ID: 10683544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Economic evaluation of various hepatitis B vaccination Strategies in Switzerland].
    Zurn P; Danthine JP
    Soz Praventivmed; 1998; 43 Suppl 1():S61-4, S134-7. PubMed ID: 9833269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits.
    Boccalini S; Taddei C; Ceccherini V; Bechini A; Levi M; Bartolozzi D; Bonanni P
    Hum Vaccin Immunother; 2013 May; 9(5):1119-28. PubMed ID: 23376840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
    Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
    [No Abstract]   [Full Text] [Related]  

  • 12. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
    Bloom BS; Hillman AL; Fendrick AM; Schwartz JS
    Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.
    Ginsberg GM; Berger S; Shouval D
    Bull World Health Organ; 1992; 70(6):757-67. PubMed ID: 1486673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela].
    Fernández Barboza R; Rivero D; Echeverría B; Machado IV
    Bol Oficina Sanit Panam; 1991 Jul; 111(1):16-23. PubMed ID: 1834080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Economic evaluation of various hepatitis B vaccination strategies in children and adolescents].
    Szucs TD; Smala A; Berger K; Windorfer A
    Med Klin (Munich); 1998 Aug; 93(8):468-77. PubMed ID: 9747102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
    Wu GY; Gong YL; Yu SL; Shao RT; Qin HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):474-8. PubMed ID: 15231120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of hepatitis B vaccination of prison inmates.
    Pisu M; Meltzer MI; Lyerla R
    Vaccine; 2002 Dec; 21(3-4):312-21. PubMed ID: 12450707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness.
    Da Villa G; Sepe A
    Vaccine; 1999 Mar; 17(13-14):1734-8. PubMed ID: 10194831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of economic outcomes of "hepatitis B vaccine event reported by media" in China, 2013].
    Zhang SX; Sun PP; Xia Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Aug; 52(8):837-841. PubMed ID: 30107719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.